Pricing Log in Create free account

BillionToOne, Inc. (BLLN) vs RadNet, Inc. (RDNT)

BillionToOne, Inc. and RadNet, Inc. are both Diagnostics & Research companies. RadNet, Inc. is the larger, with a market value of $5.5B against $4.9B — 1.1× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; BillionToOne, Inc. trades at 95.0×. BillionToOne, Inc. has the higher net margin (8.35% vs −0.93%) and the higher return on invested capital (34.1% vs 2.24%). Across the 18 metrics below, BillionToOne, Inc. leads on 14 and RadNet, Inc. on 4.

Valuation

Metric BLLN RDNT Diagnostics & Research median
P/E 94.98 n/m 35.56
P/S 11.45 2.35 4.37
P/B 8.48 3.82 3.06
Price to free cash flow 137.17 164.99 35.76
EV/EBITDA 73.61 19.29 24.35
EV/Sales 10.30 2.62 5.51
Earnings yield 1.05% (0.39%) (1.89%)
Free cash flow yield 0.73% 0.61% (0.15%)

Profitability

Metric BLLN RDNT Diagnostics & Research median
Gross margin 71.27% 11.53% 50.89%
Operating margin 10.90% 3.12% (8.57%)
Net margin 8.35% (0.93%) (6.37%)
Free cash flow margin 8.35% 3.28% 0.00%
Return on equity 23.27% (1.64%) (2.92%)
Return on assets 9.09% (0.55%) (6.71%)
Return on invested capital 34.10% 2.24% 0.00%

Growth

Metric BLLN RDNT Diagnostics & Research median
Revenue growth (TTM) — 18.92% 7.69%
EPS growth (last fiscal year) 103.40% (725.00%) 25.92%
Revenue growth, 5-year CAGR — 13.74% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BLLN RDNT Diagnostics & Research median
Debt to equity 0.17 0.94 0.11
Current ratio 11.69 1.48 2.02
Net debt to EBITDA (15.70) 1.16 0.70

Dividend

Metric BLLN RDNT Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BLLN RDNT Diagnostics & Research median
Market cap 4.85b 5.54b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack